UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-A

 

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

IMMUDYNE, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   76-0238453
(State of Incorporation
or Organization) 		  (I.R.S. Employer
Identification No.)
   

1460 Broadway

New York, NY

  10036
(Address of principal executive offices)   (Zip code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

None.

 

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box.  ☐

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box.  ☒

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box  ☐

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: Not applicable.

 

Securities to be registered pursuant to Section 12(g) of the Act:

Common Stock, par value $0.01 per share

 

 

 

 

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

 

Immudyne, Inc. (the “ Registrant ”) hereby incorporates by reference the description of its common stock, par value $0.01 per share, to be registered hereunder contained under the heading “Description of Capital Stock” in the Registrant’s Registration Statement on Form S-1 (File No. 333-184487), as originally filed with the Securities and Exchange Commission (the “ Commission ”) on October 18, 2012, as subsequently amended on December 5, 2012, January 3, 2013, January 23, 2013 and February 7, 2013 (the “ Registration Statement ”).

 

Item 2. Exhibits.

 

3.1 Certificate of Incorporation of Immudyne, Inc. (Incorporated herein by reference to Exhibit 3.1 to the Company’s Registration on Form S-1 (File No. 333-184487) filed on October 18, 2012)
   
3.2 Certificate of Amendment of Certificate of Incorporation of Immudyne, Inc. (Incorporated herein by reference to Exhibit 3.2 to the Company’s Registration on Form S-1 (File No. 333-184487) filed on October 18, 2012)
   
3.3 Certificate of Amendment of Certificate of Incorporation of Immudyne, Inc. (Incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 333-184487) filed on September 25, 2017)
   
3.4 Bylaws of Immudyne, Inc. as currently in effect (Incorporated herein by reference to Exhibit 3.3 to the Company’s Registration on Form S-1 (File No. 333-184487) filed on October 18, 2012)

 

  2  

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Immudyne, Inc.
     
Date: October 16, 2017 By: /s/ Mark McLaughlin
  Name: Mark McLaughlin
  Title: Chief Executive Officer

 

 

3